Drug Description in Trials / DrugBank / KEGG DRUG
Search results
No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
---|---|---|---|---|---|---|
1 | Bacillus subtilis | [1] Bacillus subtilis Bacillus subtilis (Bacillus subtilis) | - | - | - | [1] 6 6 💬
|
2 | Live combined bacillus subtilis and enterococcus faecium enteric-coated capsules combined with bortezomib+dexamethasone/bortezomib+dexamethasone+daratumumab/single daratumumab | [3] Bortezomib Bortezomib,Daratumumab, Dexamethasone | [5] Dexamethasone
Dexamethasone
,Dexamethasone sodium phosphate , Bortezomib , Dexamethasone phosphate , Daratumumab 💬 | [3] CD38 CD38,NR3C1, PSMB5 💬 | [15] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬 | [1] 28 28 💬
|